BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28650560)

  • 1. Uncovering the role of brain-derived neurotrophic factor/tyrosine kinase receptor B signaling in head and neck malignancies.
    de Moraes JK; Wagner VP; Fonseca FP; Vargas PA; de Farias CB; Roesler R; Martins MD
    J Oral Pathol Med; 2018 Mar; 47(3):221-227. PubMed ID: 28650560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma.
    Lee J; Jiffar T; Kupferman ME
    PLoS One; 2012; 7(1):e30246. PubMed ID: 22276165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BDNF mediated TrkB activation contributes to the EMT progression and the poor prognosis in human salivary adenoid cystic carcinoma.
    Jia S; Wang W; Hu Z; Shan C; Wang L; Wu B; Yang Z; Yang X; Lei D
    Oral Oncol; 2015 Jan; 51(1):64-70. PubMed ID: 25456007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schwann cells promote EMT and the Schwann-like differentiation of salivary adenoid cystic carcinoma cells via the BDNF/TrkB axis.
    Shan C; Wei J; Hou R; Wu B; Yang Z; Wang L; Lei D; Yang X
    Oncol Rep; 2016 Jan; 35(1):427-35. PubMed ID: 26530352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma.
    Kupferman ME; Jiffar T; El-Naggar A; Yilmaz T; Zhou G; Xie T; Feng L; Wang J; Holsinger FC; Yu D; Myers JN
    Oncogene; 2010 Apr; 29(14):2047-59. PubMed ID: 20101235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-Derived Neurotrophin and TrkB in Head and Neck Squamous Cell Carcinoma.
    Dudás J; Riml A; Tuertscher R; Pritz C; Steinbichler TB; Schartinger VH; Sprung S; Glueckert R; Schrott-Fischer A; Johnson Chacko L; Riechelmann H
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
    Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
    Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer.
    Serafim Junior V; Fernandes GMM; Oliveira-Cucolo JG; Pavarino EC; Goloni-Bertollo EM
    Cytokine; 2020 Dec; 136():155270. PubMed ID: 32911446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of BDNF/TrkB/Akt pathway is associated with aggressiveness and unfavorable survival in oral squamous cell carcinoma.
    Moraes JK; Wagner VP; Fonseca FP; Amaral-Silva GKD; de Farias CB; Pilar EFS; Gregianin L; Roesler R; Vargas PA; Martins MD
    Oral Dis; 2019 Nov; 25(8):1925-1936. PubMed ID: 31498938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
    Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
    Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
    Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
    Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral squamous cell carcinoma-released brain-derived neurotrophic factor contributes to oral cancer pain by peripheral tropomyosin receptor kinase B activation.
    Grayson M; Arris D; Wu P; Merlo J; Ibrahim T; Fang-Mei C; Valenzuela V; Ganatra S; Ruparel S
    Pain; 2022 Mar; 163(3):496-507. PubMed ID: 34321412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of tropomyosin-related kinase B (TrkB) in head and neck cancer.
    Zhu L; Werner JA; Mandic R
    Anticancer Res; 2007; 27(5A):3121-6. PubMed ID: 17970052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of tyrosine kinase receptor B and brain-derived neurotrophic factor expression in salivary duct carcinoma.
    Kondo Y; Hirabayashi K; Carreras J; Tsukinoki K; Ota Y; Okami K; Nakamura N
    Ann Diagn Pathol; 2021 Feb; 50():151673. PubMed ID: 33248386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer.
    Kimura S; Harada T; Ijichi K; Tanaka K; Liu R; Shibahara D; Kawano Y; Otsubo K; Yoneshima Y; Iwama E; Nakanishi Y; Okamoto I
    Lung Cancer; 2018 Jun; 120():98-107. PubMed ID: 29748024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma.
    Odate S; Nakamura K; Onishi H; Kojima M; Uchiyama A; Nakano K; Kato M; Tanaka M; Katano M
    Lung Cancer; 2013 Mar; 79(3):205-14. PubMed ID: 23312550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.
    Vanhecke E; Adriaenssens E; Verbeke S; Meignan S; Germain E; Berteaux N; Nurcombe V; Le Bourhis X; Hondermarck H
    Clin Cancer Res; 2011 Apr; 17(7):1741-52. PubMed ID: 21350004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
    Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
    PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
    Li Z; Jaboin J; Dennis PA; Thiele CJ
    Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDNF/TrkB signaling protects HT-29 human colon cancer cells from EGFR inhibition.
    de Farias CB; Heinen TE; dos Santos RP; Abujamra AL; Schwartsmann G; Roesler R
    Biochem Biophys Res Commun; 2012 Aug; 425(2):328-32. PubMed ID: 22842573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.